about
Fat, Sugar, and Bone Health: A Complex RelationshipIP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet-Induced Skeletal Involution.Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease.Wnt signaling and cellular metabolism in osteoblasts.Pathophysiology of Bone Fragility in Patients with Diabetes.Bone Cell Bioenergetics and Skeletal Energy Homeostasis.A Mendelian Randomization Study of the Effect of Type-2 Diabetes and Glycemic Traits on Bone Mineral Density.Fatty acid metabolism by the osteoblast.Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitusFenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model.Clinical fractures among older men with diabetes are mediated by diabetic complications.Hydrogen-rich saline prevents bone loss in diabetic rats induced by streptozotocin.Low bone turnover in premenopausal women with type 2 diabetes mellitus as an early process of diabetes-associated bone alterations: a cross-sectional study.Role of Galectin-3 in Bone Cell Differentiation, Bone Pathophysiology and Vascular Osteogenesis.Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus.Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis.Differences between biological and chronological age-at-death in human skeletal remains: A change of perspective.Potein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety.Clinical implications of bone marrow adiposity.Insulin resistance and bone: a biological partnership.Characterization of an insulinotropic peptide from skin secretions of Odorrana andersonii.The emerging role of bone marrow adipose tissue in bone health and dysfunction.Glucose metabolism in bone.Mitochondrial Point Mutation m.3243A>G Associates With Lower Bone Mineral Density, Thinner Cortices, and Reduced Bone Strength: A Case-Control Study.Elevated Levels of Serum β2-Glycoprotein I/Oxidized Low-Density Lipoprotein Complexes Are Associated with Cerebral Infarction in Patients with Type 2 Diabetes Mellitus.Structure and Function of Bone Marrow Adipocytes.Contribution of metabolic disease to bone fragility in MAGP1-deficient mice.Influence of Apelin-13 on osteoporosis in Type-2 diabetes mellitus: A clinical study.Osteoporosis Is Associated with Deteriorating Clinical Status in Adults with Cystic Fibrosis.Sarcopenia: a chronic complication of type 2 diabetes mellitus.Latent Autoimmune Diabetes in Adults: Current Status and New Horizons.Association of Insulin Resistance with Lower Bone Volume and Strength Index of the Proximal Femur in Nondiabetic Postmenopausal Women.Effect of duration of diabetes on bone mineral density: a population study on East Asian malesCMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone lossSkeletal Status, Body Composition, and Glycaemic Control in Adolescents with Type 1 Diabetes MellitusAqueous Extract of Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats
P2860
Q33749548-4B0489C9-B3B9-4AEE-8052-57D32D732FEDQ38430822-0A4C3AB3-6347-4CEF-B84B-6724430198BCQ38688345-9F12DA99-C92C-4FF6-8C41-BDBD4C235789Q39020338-E33031EA-F9BD-4EBE-B0F1-EF8C3B1B398AQ39127683-D7F7F0CE-7739-4CDA-874B-B097AB65DC2FQ39137277-3BE0CC8A-B64C-4F4A-AAD7-CD6CEF0112D7Q40421916-BB0E9223-3BE9-4C57-A662-6DCD1EB3EEAFQ42001274-C9166106-65F4-4CDB-920A-18AFC4666F49Q42280449-BFF8471D-B986-4ADB-9AD6-FF445F7C971FQ42377473-B168FAE5-F2DE-465F-9C1D-8EDC3829BCDEQ45071815-55507AEF-0D01-49D3-8FF1-3AA380326576Q46330177-8D62AD21-F566-445A-A2E5-26F7459729BEQ47105302-19ACAEA8-CC22-49A8-804B-2DE90D9F011BQ47133991-EE316031-B59E-4012-B350-72A029F118E8Q47147079-BB137536-2C52-410C-BBF3-5FF39D3125BAQ47151037-C736D688-12B7-4AB0-BA7D-B6C43FB5AD1FQ47178384-D34380A1-6B06-47F0-A7D6-D7B7FFA75B59Q47231510-2989368F-3E6A-4F8D-85AF-8307337B750FQ47707495-3DDDB527-DE47-4197-9CCD-FA0DCE9810EDQ48034150-993A149A-D690-4DA6-823C-3B9DDD810FACQ48047130-3D51CB21-AEC2-4DBC-8BC6-78BC28FE9CFCQ48245873-F8FDE510-EC13-486D-8366-B36D9A9680B8Q48287561-D203FFE5-56FE-4242-8BAB-6BC475DCB5B6Q50172954-075B929C-CD94-48F9-BC85-BBF9477FBB6FQ50428854-2DDEFB02-36DD-4DA6-AD6C-530A83DC0F87Q51816539-9D1D0647-26BD-49A2-85B4-054AD2D6DC8DQ52371615-46D9E08A-1241-4EF6-9C88-DF2882668A77Q52709053-9BB593FA-8F2A-4CD8-8C53-CCF2FCED4EBBQ52727794-99CAC94A-E55D-4067-B362-6BDBE9BA1B21Q54940887-BB74762B-884F-4379-A46F-057BACE86265Q55180835-1C7D1935-3F59-4FD1-848F-917B41B14FF1Q55279966-2D1A7A1C-5DB2-4359-87A2-BBBD519D0F13Q55397117-5A1C52F2-F785-4C4D-AE44-974BEDDBC781Q55473378-3347EBAD-CDAD-481A-A921-0B2DA53965B5Q57213051-6D15B03A-AF3F-4AAD-BDFF-9E394FF24221Q57497106-F3274EB4-5CC7-4428-804A-6829CCE05835Q58766909-88C1F95D-AE27-4C75-B30E-C85FCA58B12FQ59136291-FCC75EDD-010F-4133-B2BC-7D5BF1297E2D
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Mechanisms of diabetes mellitus-induced bone fragility.
@ast
Mechanisms of diabetes mellitus-induced bone fragility.
@en
type
label
Mechanisms of diabetes mellitus-induced bone fragility.
@ast
Mechanisms of diabetes mellitus-induced bone fragility.
@en
prefLabel
Mechanisms of diabetes mellitus-induced bone fragility.
@ast
Mechanisms of diabetes mellitus-induced bone fragility.
@en
P2093
P356
P1476
Mechanisms of diabetes mellitus-induced bone fragility.
@en
P2093
Ann V Schwartz
Dominique D Pierroz
IOF Bone and Diabetes Working Group
Manju Chandran
Serge L Ferrari
P2888
P304
P356
10.1038/NRENDO.2016.153
P577
2016-09-23T00:00:00Z
P6179
1048760700